Nanil Health
Creating a world without dementia
Creating a world without dementia
Through our tau based therapeutics discovery programs, we are building a future beyond symptom management for Alzheimer's disease
De-novo antibody design
De-novo antibody design
We partner with the best Artificial Intelligence based synthetic biology companies to test antibodies with highest chances of success.
Pre-symptomatic stages
Pre-symptomatic stages
We aim to develop drugs that will hit pre-symptomatic stages of the disease using a combination of molecular biomarkers and therapies.
Phospho-tau as target
Phospho-tau as target
We target the Tau protein and its related phosphorylation post-translational modifications.